Effect of Dead Sea climatotherapy on psoriasis; a prospective cohort study T Emmanuel, D Lybæk, C Johansen, L Iversen Frontiers in medicine 7, 83, 2020 | 24 | 2020 |
HSP90 inhibitor RGRN‐305 for oral treatment of plaque‐type psoriasis: efficacy, safety and biomarker results in an open‐label proof‐of‐concept study A Bregnhøj, KKH Thuesen, T Emmanuel, T Litman, CL Grek, ... British Journal of Dermatology 186 (5), 861-874, 2022 | 22 | 2022 |
Tissue-resident memory T cells in skin diseases: a systematic review T Emmanuel, J Mistegård, A Bregnhøj, C Johansen, L Iversen International Journal of Molecular Sciences 22 (16), 9004, 2021 | 15 | 2021 |
Non-random plaque-site recurrence of psoriasis in patients treated with dead sea climatotherapy T Emmanuel, D Lybaek, C Johansen, L Iversen Acta dermato-venereologica 99 (10), 909-910, 2019 | 14 | 2019 |
Artificial intelligence-assisted identification and quantification of osteoclasts T Emmanuel, A Brüel, JS Thomsen, T Steiniche, MB Brent MethodsX 8, 101272, 2021 | 11 | 2021 |
Hypobaric hypoxia deteriorates bone mass and strength in mice MB Brent, T Emmanuel, U Simonsen, A Brüel, JS Thomsen Bone 154, 116203, 2022 | 10 | 2022 |
Early intervention and disease memory in psoriasis: A literature review H Ben Abdallah, T Emmanuel, A Bregnhøj, C Johansen, L Iversen JEADV Clinical Practice 1 (4), 307-316, 2022 | 9 | 2022 |
MicroRNA-106b regulates expression of the tumour suppressors p21 and TXNIP and promotes tumour cell proliferation in mycosis fungoides LM Lindahl, M Gluud, T Emmanuel, EA Thomsen, HU Tengpeng, ... Acta Dermato-Venereologica 100 (16), 2020 | 7 | 2020 |
Climatotherapy at the Dead Sea for psoriasis is a highly effective anti‐inflammatory treatment in the short term: An immunohistochemical study T Emmanuel, A Petersen, HI Houborg, AB Rønsholdt, D Lybæk, ... Experimental Dermatology 31 (8), 1136-1144, 2022 | 5 | 2022 |
Quantification of Immunohistochemically Stained Cells in Skin Biopsies T Emmanuel, MB Brent, L Iversen, C Johansen Dermatopathology 9 (2), 82-93, 2022 | 3 | 2022 |
Method for high‐plex analysis of immune cells in human skin using the GeoMx system B Ignatov, D Sortebech, T Emmanuel, E Zhuravleva, L Eidsmo Scandinavian Journal of Immunology 99 (1), e13326, 2024 | 2 | 2024 |
Contemporary Advances in Computer-Assisted Bone Histomorphometry and Identification of Bone Cells in Culture MB Brent, T Emmanuel Calcified Tissue International 112 (1), 1-12, 2023 | 2 | 2023 |
Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305 in Hidradenitis Suppurativa: A Parallel-Design Double-Blind Trial HB Abdallah, A Bregnhøj, T Emmanuel, G Ghatnekar, C Johansen, ... JAMA dermatology 160 (1), 63-70, 2024 | 1 | 2024 |
Effects of bendroflumethiazide on bone mineral density; results from the BONATHIAD randomized double-blind placebo-controlled cohort study T Emmanuel, C Kruse, JS Leere, TH Poulsen, P Vestergaard Bone Reports 13, 100737, 2020 | 1 | 2020 |
ERAP1 and ERAP2 Gene Variants as Potential Clinical Biomarkers of Anti-IL-17A Response in Psoriasis Vulgaris L Kronborg, EO Hansen, T Bertelsen, AH Rittig, T Emmanuel, ... Clinical and Experimental Dermatology, llae128, 2024 | | 2024 |
Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory T Emmanuel, B Ignatov, T Bertelsen, T Litman, MM Nielsen, MB Brent, ... International Journal of Molecular Sciences 25 (11), 6086, 2024 | | 2024 |
056 Highly Multiplexed Digital Spatial Profiling of Resolved Psoriasis Skin From Dead Sea Climatotherapy or Secukinumab Treated Patients T Emmanuel, T Litman, B Ignatov, T Bertelsen, T Steiniche, D Lybæk, ... Journal of Investigative Dermatology 142 (12), S190, 2022 | | 2022 |
CLIMATOTHERAPY AT THE DEAD SEA FOR PSORIASIS PATIENTS IS A HIGHLY EFFECTIVE TREATMENT IN THE SHORT TERM: AN IMMUNOHISTOCHEMICAL STUDY T Emmanuel, A Petersen, H Houborg, A Ronsholdt, D Lybaek, T Steiniche, ... ACTA DERMATO-VENEREOLOGICA 102, 48-49, 2022 | | 2022 |
Quantification of Immunohistochemically Stained Cells in Skin Biopsies. Dermatopathology 2022, 9, 82–94 T Emmanuel, MB Brent, L Iversen, C Johansen s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
Heat shock protein 90 inhibitor RGRN-305 for oral treatment of plaque-type psoriasis: efficacy, safety and biomarker results in an open-label, proof-of-concept study A Bregnhoj, KKH Thuesen, T Emmanuel, T Litman, CL Grek, ... BRITISH JOURNAL OF DERMATOLOGY 186 (1), E12-E12, 2022 | | 2022 |